2014
Tu1354 PerOral Endoscopic Myotomy (POEM) Is Equivalent to Laparoscopic Heller Myotomy (Lhm) for the Treatment of Achalasia
Kumbhari V, Tieu A, Azola A, Zein M, Shin E, Stein E, Roland B, Nandwani M, Dhalla S, Lennon A, Singh V, Canto M, Messallam A, Nguyen J, Saxena P, Gilmore C, Ravich W, Kalloo A, Pasricha P, Clarke J, Khashab M. Tu1354 PerOral Endoscopic Myotomy (POEM) Is Equivalent to Laparoscopic Heller Myotomy (Lhm) for the Treatment of Achalasia. Gastrointestinal Endoscopy 2014, 79: ab509-ab510. DOI: 10.1016/j.gie.2014.02.800.Peer-Reviewed Original ResearchSa1457 Pneumatic Dilatation (PD) Versus Laparoscopic Heller Myotomy (Lhm) Versus PerOral Endoscopic Myotomy (POEM) for the Treatment of Achalasia: a Single Center Experience
Kumbhari V, Tieu A, Azola A, Zein M, Shin E, Stein E, Roland B, Nandwani M, Dhalla S, Lennon A, Singh V, Canto M, Messallam A, Saxena P, Gilmore C, Ravich W, Kalloo A, Pasricha P, Clarke J, Khashab M. Sa1457 Pneumatic Dilatation (PD) Versus Laparoscopic Heller Myotomy (Lhm) Versus PerOral Endoscopic Myotomy (POEM) for the Treatment of Achalasia: a Single Center Experience. Gastrointestinal Endoscopy 2014, 79: ab220. DOI: 10.1016/j.gie.2014.05.076.Peer-Reviewed Original Research
1996
Botulinum toxin for achalasia: Long-term outcome and predictors of response
Pasricha P, Rai R, Ravich W, Hendrix T, Kalloo A. Botulinum toxin for achalasia: Long-term outcome and predictors of response. Gastroenterology 1996, 110: 1410-1415. PMID: 8613045, DOI: 10.1053/gast.1996.v110.pm8613045.Peer-Reviewed Original ResearchConceptsLong-term outcomesPredictors of responseMedian durationBotulinum toxinType of achalasiaThird of patientsMajority of patientsDuration of illnessDuration of responseLower esophageal sphincterEffective short-term reliefYears of ageShort-term reliefPrevious dilationLatter patientsToxin injectionVigorous achalasiaEsophageal sphincterRadiological characteristicsEffective treatmentAchalasiaPatientsSecond injectionResponse rateNineteen responders
1995
Intrasphincteric Botulinum Toxin for the Treatment of Achalasia
Pasricha P, Ravich W, Hendrix T, Sostre S, Jones B, Kalloo A. Intrasphincteric Botulinum Toxin for the Treatment of Achalasia. New England Journal Of Medicine 1995, 332: 774-778. PMID: 7862180, DOI: 10.1056/nejm199503233321203.Peer-Reviewed Original ResearchConceptsLower esophageal sphincterEsophageal sphincterBotulinum toxinPlacebo groupMean decreaseSymptom scoresTreatment groupsMean increaseDisorders of swallowingIntrasphincteric botulinum toxinDouble-blind trialTreatment of achalasiaMonths 14 patientsSerious adverse effectsSymptomatic improvementEsophageal retentionParalytic agentsScintigraphic studiesEsophageal scintigraphySphincterAchalasiaPatientsAdverse effectsPlaceboMonths
1987
Pharyngeal findings in 21 patients with achalasia of the esophagus
Jones B, Donner M, Rubesin S, Ravich W, Hendrix T. Pharyngeal findings in 21 patients with achalasia of the esophagus. Dysphagia 1987, 2: 87-92. PMID: 3507299, DOI: 10.1007/bf02408139.Peer-Reviewed Original Research